Meet with Karl-Rudolf Erlemann (Rudi) and Vik Pham at the San Diego Bio International Convention event happening from June 3 to 6th. We are partnering with #biotech and #consultants to advance drug assets into transformative therapies. #BIO2024 #BioInternational2024 #partneringONE #BIOEvents #pharmapartners #drugdevelopment #preclinical #toxconsultants
See you there Rudi! TOXPLUS Monitoring will be there as well. We should schedule some time!
If you're in San Antonio this week attending the Tandem meetings, let's connect and discuss the latest breakthroughs in #celltherapy and how our new digital solution helps to improve patient access to advanced therapies! DM me at Christopher Leidli 🧬 #networking #advancedtherapies #genetherapies #pharma #biotech #venturecapital
💡 What a week at #JPM2024! The future of healthcare is thrilling, from groundbreaking biotech innovations to potential pharma partnerships and beyond. Let's keep the conversation going! #BiotechShowcase #BIOatJPMWeek
According to Deloitte, developing a new drug costs about $2.3 billion. This hefty price tag is often accompanied by high hopes, but not all clinical trials are successful. Fierce Biotech has compiled a list of the top 10 clinical trial flops in 2023. Check out the article for an insightful read on the challenges of drug development. https://lnkd.in/eRjy65P6
COMING SOON! In the world of drug development, what you can’t see is often what’s most important. The journey from invisible data to life-changing therapies starts with bioanalysis. Our upcoming video series demonstrates the significant impact of bioanalysis on drug development. #UnveilingTheInvisible #Bioanalysis #WeAreAltasciences #DrugDevelopment
Will you be at the #DrugDeliverySummit? 💊 DM Dan Dobry or David Vodak if you'd like to set up some time to meet. 💡 Let's talk about the next innovation in drug development. #PharmaCDMO #ContractManufacturing #DrugDevelopment #CDMOsolutions #InnovativeTherapeutics #AIinPharma Bend Bioscience + CoreRx, Inc.
Associate Marketing Director at Altasciences | Helping Brands Write Their Stories | Reader of Paper Books
Drug development is so cool.
COMING SOON! In the world of drug development, what you can’t see is often what’s most important. The journey from invisible data to life-changing therapies starts with bioanalysis. Our upcoming video series demonstrates the significant impact of bioanalysis on drug development. #UnveilingTheInvisible #Bioanalysis #WeAreAltasciences #DrugDevelopment
Board of Director | Investor | CEO, JLC Life Sciences | Chris Voss’s Co-author “Empathetic Leadership”
I am excited to be speaking at #BIOTECHX on 9/17 and 9/18. I'll be diving into "Demystifying FAIR" and exploring why "Data Governance Isn't One Size Fits All." I look forward to engaging with industry leaders on these topics! #biotechnology #datagovernance #dataanalytics #pharmaceuticals #biopharma #datascience
I’m looking forward to presenting at Biotech X EU on AstraZeneca’s approach in leveraging real-world evidence in our efforts to speed up drug discovery and deliver medicines to patients faster. If you are attending Biotech X EU, please join the session on October 9th for a discussion on where we are currently with the utility of real-world evidence and how the next generation of real-world data will further optimize development decisions. #BiotechX #OncologyDataScience #RealWorldEvidence #DrugDiscovery
We are proud to share that we have helped a top 10 CMO secure 25 new business meetings with pharma and biotech leaders while travelling this week. Since 2013, we have helped our clients connect with the right decision-makers in the #pharma, #biotech, and #medtech industries. We look forward to continuing our mission of connecting people intelligently in the pharma and biotech service providers. 👉 𝗜𝗳 𝘆𝗼𝘂'𝗱 𝗹𝗶𝗸𝗲 𝘁𝗼 𝗸𝗻𝗼𝘄 𝗺𝗼𝗿𝗲 𝘀𝗲𝗻𝗱 𝘂𝘀 𝗮 𝗺𝗲𝘀𝘀𝗮𝗴𝗲 𝗼𝗻 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻. 👏Celebrating 10 years of connecting people in the pharma and biotech industry! #PharmaTargeting - The home of Pharma Service Providers. #pharmaserviceproviders Anil Kumar
#polishbiotech development & networking 🤝 (biotechnologist, tech transfer, entrepreneur, VC CEO)
5moHow many time we will bump into each other?;)